The pediatric catheter market is experiencing a surge in demand, pushed by the growing occurrence of pediatric urological and cardiovascular problems. As awareness about those situations grows, healthcare professionals are recommending catheterization processes more often, propelling the market forward. A superb trend within the pediatric catheters market is the escalating quantity of pediatric surgical procedures. Catheters play an essential role in numerous surgical processes, including the ones related to the urinary and vascular structures. The developing desire for minimally invasive strategies is further boosting the adoption of catheters in pediatric surgical interventions. Infection control has come to be a paramount issue in healthcare settings, specifically while managing pediatric patients. Market tendencies suggest a growing emphasis on the development of catheters with superior infection manipulation capabilities.
The shift towards home healthcare and ambulatory settings for pediatric care is influencing the market dynamics. Pediatric catheters, which might be easy to use and require minimal supervision, are gaining choice, permitting mothers, fathers, and caregivers to manage positive clinical approaches at home. This trend aligns with the wider motion toward affected person-centric care. The growth of healthcare infrastructure, particularly in rising economies, is contributing to the marketplace's worldwide boom. Increased entry to healthcare centers and a growing recognition of pediatric fitness problems are riding the demand for pediatric catheters in areas wherein such products had been formerly underutilized. Stringent regulatory frameworks and the implementation of best standards are shaping the pediatric catheter market. Manufacturers specialize in compliance with regulatory requirements, making sure the safety and efficacy of pediatric catheters are met. This commitment to first-rate is instilling confidence among healthcare specialists and end users.
Collaboration among key market gamers and healthcare businesses is fostering innovation and market expansion. Partnerships between catheter producers, research establishments, and healthcare providers are key to the improvement of customized pediatric catheter answers, addressing specific medical desires in pediatric populations. Despite the superb market tendencies, fee constraints and compensation-demanding situations continue to be noteworthy factors. Healthcare companies and parents can also face hurdles in having access to advanced pediatric catheter answers because of financial limitations and reimbursement complexities. Addressing these demanding situations could be critical for sustained marketplace growth.
Pediatric Catheters Market Size was valued at USD 8.20 Billion in 2023. The Global Pediatric Catheters industry is projected to grow from USD 8.96 Billion in 2024 to USD 18.11 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.48% during the forecast period (2024 - 2032).
In March 2024 – CoapTech, Inc., a medical device firm specializing in minimally-invasive surgery, has announced the market release and groundbreaking initial usage of its second generation magnetic balloon catheter at the patient's bedside. The magnetic balloon catheter is an essential part of the PUMA-G System™, which allows for the precise installation of gastrostomy tubes (i.e. permanent feeding tubes) using ultrasonography. These tubes are vital for providing patients with the necessary nutrition to aid in their rehabilitation.
In January 2024, Royal Philips, a prominent company in health technology, revealed that its newest TEE transducer, which aims to provide better comfort and serve a larger number of patients, had obtained FDA 510(k) clearance. Cardiovascular ultrasound has been essential in advancing the early detection of structural heart disease, thanks to the development of a groundbreaking technique known as transesophageal echocardiography (TEE) ultrasound transducer, pioneered by Philips. Transesophageal echocardiography (TEE) assists cardiologists by offering intricate visualizations of the heart and its intrinsic anatomical features.
Pediatric catheters are thin tubes from high-grade material used in the healthcare sector. This device delivers medications such as gases or fluids to patients and drains out fluids such as urine. These are inserted for the treatment of diseases and performing surgeries. The rise in the growth of the pediatric population and the growth rate of congenital heart defects and neurological disorders are influencing the markets towards positive growth.
With the rise in cardiovascular and urological diseases in the pediatric population, the demand has increased for minimally invasive surgeries. The minimally invasive procedures include catheter usage for surgical and diagnostic procedures. The advancements in pediatric catheters will eliminate infections in children; this will further propel the market’s demand at the global level.
Furthermore, the government world took the concerning initiatives to offer medical coverage to millions of patients, and programs such as Child Health Insurance Program (CHIP) provide healthcare coverage to children. These factors are boosting the market with rising opportunities.
Intended Audience
The Pediatric Catheters Market has been segmented into product type, and end user.
By product type, the market has been segmented into cardiovascular catheters, urology catheters, intravenous catheters, neurovascular catheters, specialty catheters, and others.
The market, by end user, has been segmented into hospitals and clinics, ambulatory surgical centers, and others.
The pediatric catheters market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European pediatric catheters market has been segmented into Western Europe and Eastern Europe. Western Europe, market, has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The pediatric catheters market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
On a regional basis, the Americas is anticipated to dominate the pediatric catheters market owing to the presence of a huge pediatric population suffering from various diseases. According to the World Bank Group, out of the total population, 19% population was pediatric in the US in 2017. Moreover, increasing healthcare expenditure, and well-developed technology has fueled the growth of the pediatric catheters market.
Europe is expected to hold the second largest position in the pediatric catheters market owing to the presence of well-developed healthcare sector, strong government support for research & development and high healthcare expenditure in the European countries. Well-developed technologies in Europe have also played a predominant role in the development of the European market. According to the World Bank Group, out of the total population, 18% population was pediatric in the UK in 2017.
Asia-Pacific is anticipated to be the fastest growing region in the pediatric catheters market owing to the increasing pediatric patient population. According to the World Bank Group, out of the total population, 18% population was pediatric in China in 2017.
The Middle East & Africa has the least share of the pediatric catheters market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Key Companies in the Pediatric Catheters Market include
Recent Development
In May 2022
BeiGene, a science-driven biotechnology company leader, focuses on innovative and affordable medicines for better treatment outcomes and accessing patients worldwide. The company has announced that the China National Medical Products Administration granted conditional approval for BLINCYTO injection to treat pediatric patients with refractory (R/R) CD19-positive B-cell precursor acute lymphoblastic leukemia.
In April 2022
Bendit Technologies, an Israeli medical device company, received 510(k) clearance from US Food and Drug Administration for its steerable Bendit21 microcatheter device.
This news of the clearance came after the Bendit neuro catheter was used in two life-saving procedures in the US. The Bendit technology presents a transformative paradigm in endovascular navigation for revolutionizing and accessing the vasculature. It will improve treatments of arterial and venous systems in the brain.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)